R. Di Marsico

Correlation of <i>CDA, ERCC1</i>, and <i>XPD</i> Polymorphisms with Response and Survival in Gemcitabine/Cisplatin–Treated Advanced Non–Small Cell Lung Cancer Patients

Carmelo Tibaldi, Elisa Giovannetti, Enrico Vasile et al. · Clinical Cancer Research · 2008 · 208 citations

Medicine, Molecular Genetics, Oncology +17

Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study

Marta Pestrin, Silvia Bessi, Fabio Puglisi et al. · Breast Cancer Research and Treatment · 2012 · 109 citations

Medicine, Oncology, Pharmacology +17

Clinical and Pharmacodynamic Evaluation of Metronomic Cyclophosphamide, Celecoxib, and Dexamethasone in Advanced Hormone-refractory Prostate Cancer

Andrea Fontana, Luca Galli, Anna Fioravanti et al. · Clinical Cancer Research · 2009 · 88 citations

Medicine, Pharmacology, Pharmacotherapy +17